Cargando…
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study
BACKGROUND: Parkinson disease (PD) is a neurodegenerative disorder associated with a broad spectrum of motor and nonmotor symptoms. Any proposed cure needs to address the many aspects of the disease. Stem cell therapy may have potential in this regard as indicated in recent preclinical and clinical...
Autores principales: | Jamali, Fatima, Aldughmi, Mayis, Khasawneh, Mohammad W, Dahbour, Said, Salameh, Alaa A, Awidi, Abdalla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571682/ https://www.ncbi.nlm.nih.gov/pubmed/34677138 http://dx.doi.org/10.2196/29695 |
Ejemplares similares
-
In Vivo Immunogenic Response to Allogeneic Mesenchymal Stem Cells and the Role of Preactivated Mesenchymal Stem Cells Cotransplanted with Allogeneic Islets
por: Oliveira, Régis Linhares, et al.
Publicado: (2017) -
The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study
por: Alghwiri, Alia A., et al.
Publicado: (2020) -
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
por: Dahbour, Said, et al.
Publicado: (2017) -
A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells
por: Ababneh, Nidaa A., et al.
Publicado: (2022) -
Cotransplanted Bone Marrow Derived Mesenchymal Stem Cells (MSC) Enhanced Engraftment of Hematopoietic Stem Cells in a MSC-dose Dependent Manner in NOD/SCID Mice
por: Kim, Dong Hyun, et al.
Publicado: (2006)